NCT00524992View on ClinicalTrials.gov

Evaluation of Albuminuria HIV-Infected Patients

CompletedOBSERVATIONAL
Enrollment

252

Participants

Timeline

Start Date

August 29, 2007

Study Completion Date

December 24, 2014

Conditions
HIV-Associated Focal Segmental GlomerulosclerosisHIV-Associated Collapsing GlomerulopathyProteinuriaAlbuminuriaRenal Tubular Toxicity
Trial Locations (2)

20010

Washington Hospital Center, Washington D.C.

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00524992 - Evaluation of Albuminuria HIV-Infected Patients | Biotech Hunter | Biotech Hunter